IndiaInfoline » Markets » GLENMARK

Glenmark Pharmaceuticals Ltd - Share Price

GLENMARK

Open

643.00

Prev. Close

639.50

Turnover (lac.)

12,307

Day's High

647.15

Day's Low

626.00

52 Week's High

658.20

52 Week's Low

371.00

Book Value

527

Face Value

1

Mkt Cap (Cr.)

18,070

P/E

11.38

EPS

56.3

Divi. Yield

0.39

Glenmark Pharmaceuticals LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Glenmark Pharmaceuticals LtdNews & Updates

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd668.5071.95160,371.55327.391.123,119.04104.36
Divis Laboratories Ltd4,197.3056.94111,305.67487.930.481,718.39349.25
Dr Reddys Laboratories Ltd5,283.9040.2187,906.42311.500.473,313.501,020.99
Cipla Ltd960.9031.3777,443.53413.410.523,173.39247.09
Cadila Healthcare Ltd620.4038.9663,492.52464.700.561,949.70124.49

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Glenmark Pharmaceuticals LtdSummary & Reports

Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977. The company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The company has several molecules in var... More

Registered Office

B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road,Mumbai, Maharashtra,400026

Tell. : +91-22-40189999
Website : http://www.glenmarkpharma.com
Email : complianceofficer@glenmarkpharma.com

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67162222
Website : www.kfintech.com
Email : einward.ris@kfintech.com

Latest Release by glenmark-pharmaceuticals-ltd-share-price

View

- <

Reco. Price

Jun 16,2021 08:23 AM

Target Price

Target Returns:

0.00%

Result Express

Glenmark Pharmaceuticals Ltd's Q2FY19 consolidated net profit rises 15.27% yoy to Rs246.82cr : Beats Estimates

Jun 18, 2021 09:07 PM

The company’s consolidated revenue stood at Rs2,581.33cr, up 14.39% yoy and 19.2% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Board Meeting

    Exp. Date

    28 May 2021

    Annc. Date

    19 May 2021

    GLENMARK PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Comp... More

  • Purpose

    Board Meeting

    Exp. Date

    12 Feb 2021

    Annc. Date

    01 Feb 2021

    GLENMARK PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Comp... More